EPISODE · Jan 27, 2020 · 47 MIN
413 Building a Billion Dollar Company Treating Rare Diseases w/ Dr Gordon Vanscoy
from Going Deep with Aaron Watson · host Aaron Watson
Dr. Gordon Vanscoy is the founding Chairman and CEO of PANTHERx Rare, the nation’s leading rare disease and orphan drug-focused pharmacy. PANTHERx Rare assists patients in navigating the complex process of getting orphan & precision medicines. They also help innovative biotechnology entrepreneurs get their medicines approved by insurers and healthcare providers. Prior to PANTHERx, Dr. Vanscoy developed 7 health care companies while concurrently serving in various leadership roles at the University of Pittsburgh School of Pharmacy. Today, he serves as Pitt’s Associate Dean for Business Innovation and Associate Professor of Pharmacy and Therapeutics. In this conversation, you’ll hear Dr. Vanscoy and Aaron discuss the growth of precision medicine, why he came out of semi-retirement, and the staggering rate of growth. Pittsburgh’s best conference to Expand your Mind & Fill your Heart happens once a year. Gordon Vanscoy’s Challenge; Do more research on the treatment of Rare Diseases. Connect with Gordon Vanscoy Linkedin Twitter Website If you liked this interview, check out episode 340 with Craig Markovitz where we discuss university technology transfer, creating $300m in shareholder value, and building a loyal team. Underwritten by Piper Creative Piper Creative creates podcasts, vlogs, and videos for companies. Our clients become better storytellers. How? Click here and Learn more. We work with Fortune 500s, medium-sized companies, and entrepreneurs. Sign up for one of Piper’s weekly newsletters. We curate links to Expand your Mind, Fill your Heart, and Grow your Tribe. Follow Piper as we grow YouTube Instagram Subscribe on iTunes | Stitcher | <a href= "https://overcast.fm/itunes1016307641/going-dee
What this episode covers
Dr. Gordon Vanscoy is the founding Chairman and CEO of PANTHERx Rare, the nation’s leading rare disease and orphan drug-focused pharmacy. PANTHERx Rare assists patients in navigating the complex process of getting orphan & precision medicines. They also help innovative biotechnology entrepreneurs get their medicines approved by insurers and healthcare providers. Prior to PANTHERx, Dr. Vanscoy developed 7 health care companies while concurrently serving in various leadership roles at the University of Pittsburgh School of Pharmacy. Today, he serves as Pitt’s Associate Dean for Business Innovation and Associate Professor of Pharmacy and Therapeutics. In this conversation, you’ll hear Dr. Vanscoy and Aaron discuss the growth of precision medicine, why he came out of semi-retirement, and the staggering rate of growth. Pittsburgh’s best conference to Expand your Mind & Fill your Heart happens once a year. Gordon Vanscoy’s Challenge; Do more research on the treatment of Rare Diseases. Connect with Gordon Vanscoy Linkedin Twitter Website If you liked this interview, check out episode 340 with Craig Markovitz where we discuss university technology transfer, creating $300m in shareholder value, and building a loyal team. Underwritten by Piper Creative Piper Creative creates podcasts, vlogs, and videos for companies. Our clients become better storytellers. How? Click here and Learn more. We work with Fortune 500s, medium-sized companies, and entrepreneurs. Sign up for one of Piper’s weekly newsletters. We curate links to Expand your Mind, Fill your Heart, and Grow your Tribe. Follow Piper as we grow YouTube Instagram Subscribe on iTunes | Stitcher | <a href= "https://overcast.fm/itunes1016307641/going-dee
NOW PLAYING
413 Building a Billion Dollar Company Treating Rare Diseases w/ Dr Gordon Vanscoy
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Jan 2, 2026 ·47m
Dec 21, 2025 ·46m